Zynex stock gains amid report it’s pursuing strategic options, including a sale

Zynex (NASDAQ:ZYXI) rose 2% amid a report that the medical machine maker is evaluating its choices, together with a attainable sale.

The corporate is working with Cantor Fitzgerald to evaluate its choices, together with a takeover, a merger, a divestiture, a recapitalization, or one other transaction, in keeping with a Bloomberg report, which cited individuals acquainted.

There isn’t any certainty that Zynex (ZYXI) will resolve to pursue a deal, in keeping with the report. Zynex has a market cap of $283 million.